Scarica l'app Stockscreener
2.69
4.95%
-0.14
Dopo l'orario di chiusura:
2.65
-0.04
-1.49%
Precedente Chiudi:
$2.83
Aprire:
$2.8
Volume 24 ore:
105.23K
Relative Volume:
1.17
Capitalizzazione di mercato:
$34.55M
Reddito:
-
Utile/perdita netta:
$-70.20M
Rapporto P/E:
-0.06
EPS:
-44.82
Flusso di cassa netto:
$-50.66M
1 W Prestazione:
-4.27%
1M Prestazione:
+24.25%
6M Prestazione:
-48.17%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.55
$2.86
Intervallo di 1 settimana:
$2.55
$2.975
Portata 52W:
$1.70
$19.40
Onkure Therapeutics Inc Stock (OKUR) Company Profile
Nome
Onkure Therapeutics Inc
Settore
Industria
Telefono
(720) 307-2892
Indirizzo
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Confronta OKUR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OKUR
Onkure Therapeutics Inc
|
2.69 | 37.48M | 0 | -70.20M | -50.66M | -44.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-30 | Iniziato | Evercore ISI | Outperform |
| 2024-12-05 | Iniziato | Leerink Partners | Outperform |
| 2024-10-10 | Iniziato | Oppenheimer | Outperform |
| 2023-12-15 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-12-15 | Downgrade | Jefferies | Buy → Hold |
| 2023-12-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-12-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2023-12-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-11-15 | Iniziato | William Blair | Outperform |
| 2023-08-28 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-03 | Iniziato | BofA Securities | Buy |
| 2022-09-19 | Ripresa | H.C. Wainwright | Buy |
| 2022-01-27 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-22 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-05-04 | Iniziato | Jefferies | Buy |
| 2021-05-04 | Iniziato | Piper Sandler | Overweight |
| 2021-05-04 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Onkure Therapeutics Inc Borsa (OKUR) Ultime notizie
Is OnKure Therapeutics Inc. stock bottoming out2025 Market WrapUp & AI Based Buy and Sell Signals - Newser
Can OnKure Therapeutics Inc. hit a new high this monthQuarterly Growth Report & AI Forecast Swing Trade Picks - Newser
When is the best time to exit OnKure Therapeutics Inc.Trade Entry Report & Reliable Price Action Trade Plans - Newser
Has OnKure Therapeutics Inc. formed a bullish divergence2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser
Developing predictive dashboards with OnKure Therapeutics Inc. dataPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - Newser
Published on: 2025-09-03 07:13:09 - Newser
Using economic indicators to assess OnKure Therapeutics Inc. potentialMarket Weekly Review & AI Driven Price Predictions - Newser
Building trade automation scripts for OnKure Therapeutics Inc.Portfolio Risk Report & Weekly Consistent Profit Watchlists - Newser
How to track smart money flows in OnKure Therapeutics Inc.July 2025 Recap & Precise Swing Trade Alerts - Newser
OnKure Therapeutics Inc. stock daily chart insightsJuly 2025 Update & High Yield Stock Recommendations - Newser
What moving averages say about OnKure Therapeutics Inc.2025 Sector Review & High Yield Stock Recommendations - Newser
Real time alert setup for OnKure Therapeutics Inc. performanceJuly 2025 Breakouts & Real-Time Volume Analysis - Newser
Market reaction to OnKure Therapeutics Inc.’s recent newsWall Street Watch & Low Risk Entry Point Guides - Newser
What to do if you’re stuck in OnKure Therapeutics Inc.2025 Market Overview & Expert Curated Trade Ideas - Newser
Using RSI to spot recovery in OnKure Therapeutics Inc.Market Growth Report & Weekly Top Gainers Trade List - Newser
OnKure Therapeutics Inc. recovery potential after sell offPortfolio Risk Report & Safe Entry Zone Tips - Newser
Leading vs lagging indicators on OnKure Therapeutics Inc. performanceEarnings Overview Summary & Advanced Technical Signal Analysis - Newser
Is a relief rally coming for OnKure Therapeutics Inc. holdersMarket Activity Recap & Accurate Intraday Trading Signals - Newser
Using data models to predict OnKure Therapeutics Inc. stock movementWeekly Risk Summary & Precise Trade Entry Recommendations - Newser
Is OnKure Therapeutics Inc. still worth holding after the dip2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
What does recent volatility data suggest for OnKure Therapeutics Inc.Gap Down & Real-Time Stock Entry Alerts - Newser
Using flow based indicators on OnKure Therapeutics Inc.July 2025 Analyst Calls & Scalable Portfolio Growth Ideas - Newser
How sensitive is OnKure Therapeutics Inc. to inflationMarket Trend Report & Verified Momentum Watchlists - khodrobank.com
What earnings revisions data tells us about OnKure Therapeutics Inc.2025 Dividend Review & Stepwise Trade Execution Plans - Newser
What to expect from OnKure Therapeutics Inc. in the next 30 daysPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
What is the PEG ratio of OnKure Therapeutics Inc.July 2025 Outlook & Verified Swing Trading Watchlists - khodrobank.com
Is OnKure Therapeutics Inc. a strong growth stockQuarterly Profit Report & Technical Buy Zone Confirmations - khodrobank.com
How liquid is OnKure Therapeutics Inc. stockJuly 2025 Sentiment & Stock Portfolio Risk Control - khodrobank.com
Has OnKure Therapeutics Inc. found a price floorJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser
What are OnKure Therapeutics Inc.’s recent SEC filings showingJuly 2025 Snapshot & Pattern Based Trade Signal System - khodrobank.com
Does OnKure Therapeutics Inc. outperform in volatile marketsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - khodrobank.com
Strategies to average down on OnKure Therapeutics Inc.Quarterly Trade Report & Community Consensus Trade Alerts - Newser
Is OnKure Therapeutics Inc. stock technically oversoldJuly 2025 Fed Impact & Weekly Market Pulse Alerts - khodrobank.com
Can OnKure Therapeutics Inc. rally from current levelsJuly 2025 PreEarnings & Long-Term Investment Growth Plans - Newser
How to build a dashboard for OnKure Therapeutics Inc. stockJuly 2025 Analyst Calls & Safe Capital Growth Plans - Newser
Onkure Therapeutics Inc Azioni (OKUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Onkure Therapeutics Inc Azioni (OKUR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Leverone Jason A. | Chief Financial Officer |
Jun 23 '25 |
Sale |
2.38 |
303 |
722 |
12,906 |
| Cormorant Asset Management, LP | Former 10% Owner |
May 15 '25 |
Sale |
1.85 |
1,813,439 |
3,363,023 |
0 |
| ACORN BIOVENTURES, L.P. | 10% Owner |
May 15 '25 |
Buy |
1.85 |
1,129,730 |
2,090,000 |
1,129,730 |
| ACORN BIOVENTURES, L.P. | 10% Owner |
May 15 '25 |
Buy |
1.85 |
270,270 |
500,000 |
1,709,944 |
| Cormorant Asset Management, LP | 10% Owner |
May 12 '25 |
Sale |
1.99 |
24,300 |
48,236 |
1,813,439 |
| Saccomano Nicholas A | President and CEO |
Apr 07 '25 |
Sale |
2.67 |
516 |
1,378 |
3,682 |
| Saccomano Nicholas A | President and CEO |
Apr 04 '25 |
Sale |
3.33 |
358 |
1,191 |
4,198 |
| Leverone Jason A. | Chief Financial Officer |
Apr 07 '25 |
Sale |
2.67 |
1,844 |
4,925 |
13,209 |
| Leverone Jason A. | Chief Financial Officer |
Apr 04 '25 |
Sale |
3.33 |
1,278 |
4,253 |
15,053 |
| Leonard Braden Michael | 10% Owner |
Sep 25 '24 |
Buy |
1.50 |
68,746 |
102,872 |
3,457,395 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):